There are no useful monoclonal antibody treatments left against new COVID variants

Close Up Scientist using microscope in laboratory room while making medical testing and research

The last of six COVID monoclonal antibody treatments has lost its federal authorization because, like the others, it no longer works against the newest Omicron subvariants.

Ask the Pediatrician: How do violent movies and video games affect children?

Previous article

Severe seizures are rising, especially among minorities

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations